Research and Markets has announced the addition of the "US Hepatitis B Market and Competitive Landscape Highlights - 2016" drug pipelines to their offering.
US Hepatitis B Market and Competitive Landscape Highlights - 2016, provides comprehensive insights into Hepatitis B pipeline products, Hepatitis B epidemiology, Hepatitis B market valuations and forecast, Hepatitis B products sales and competitive landscape in the US.
The research is classified into nine sections - Hepatitis B overview including etiology, pathophysiology, and diagnosis, Hepatitis B treatment options, Hepatitis B pipeline products, Hepatitis B market analysis comprising of Hepatitis B epidemiology, key products marketed for Hepatitis B, market valuations and forecast, products sales and market shares.
Key Topics Covered:
For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/hm55xc/us_hepatitis_b
View source version on businesswire.com: http://www.businesswire.com/news/home/20161005006024/en/Business Wire
Last updated on: 05/10/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.